CIK 0000711377
- Large accelerated filer
NEOGEN CORP
Sign in to watch- Ticker
- NEOG
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- MI
- Entity type
- Operating
- EIN
- 382367843
- Phone
- +1 517-372-9200
- Business address
- 620 LESHER PLACE, LANSING, MI, 48912
- Open-market buys, last 90 days
- $6,035
- in 1 filing
- Open-market sales, last 90 days
- $114,676
- in 1 filing
Net −$108,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-26 | CAPELLO JEFFREY D Director | Option exercise · Common Stock (Right to Buy) | +13,716 | 32,132 | ||
| 2023-10-26 | CAPELLO JEFFREY D Director | Option exercise · Restricted Stock Units | +5,329 | 9,470 | ||
| 2023-10-26 | BOREL JAMES C Director | Option exercise · Common Stock (Right to Buy) | +13,716 | 66,217 | ||
| 2023-10-26 | BOREL JAMES C Director | Option exercise · Restricted Stock Units | +5,329 | 9,706 | ||
| 2023-10-26 | BOEHM WILLIAM T Director | Option exercise · Common Stock (Right to Buy) | +13,716 | 72,883 | ||
| 2023-10-26 | BOEHM WILLIAM T Director | Option exercise · Restricted Stock Units | +5,329 | 9,706 | ||
| 2023-10-26 | Lilly Jason Warren Vice President | Option exercise · Common Stock (Right to Buy) | +25,004 | 225,196 | ||
| 2023-10-26 | Lilly Jason Warren Vice President | Option exercise · Restricted Stock Units | +14,574 | 34,038 | ||
| 2023-10-26 | Rocklin Amy M Chief Legal Officer | Option exercise · Common Stock (Right to Buy) | +109,725 | 254,255 | ||
| 2023-10-26 | Rocklin Amy M Chief Legal Officer | Option exercise · Restricted Stock Units | +28,424 | 49,632 | ||
| 2023-10-26 | Jones Douglas Edward Chief Operating Officer | Option exercise · Common Stock (Right to Buy) | +179,550 | 411,226 | ||
| 2023-10-26 | Jones Douglas Edward Chief Operating Officer | Option exercise · Restricted Stock Units | +46,512 | 78,122 | ||
| 2023-10-26 | Naemura David H. CFO | Option exercise · Common Stock (Right to Buy) | +179,550 | 351,963 | ||
| 2023-10-26 | Naemura David H. CFO | Option exercise · Restricted Stock Units | +46,512 | 85,247 | ||
| 2023-10-26 | ADENT JOHN EDWARD CEO | Option exercise · Common Stock (Right to Buy) | +698,251 | 1,965,248 | ||
| 2023-10-26 | ADENT JOHN EDWARD CEO | Option exercise · Restricted Stock Units | +116,279 | 199,794 | ||
| 2023-10-25 | Jones Douglas Edward Chief Operating Officer | Purchase | +10,000 | $15.17 | $152K | 36,131 |
| 2023-10-13 | Lilly Jason Warren Vice President | Sale | −351 | $15.10 | $5K | 26,744 |
| 2023-10-12 | Tobin James P Director | Purchase | +3,000 | $15.19 | $46K | 20,392 |
| 2023-10-11 | BOEHM WILLIAM T Director | Sale | −2,591 | $15.61 | $40K | 24,509 |
Page 19 of 21 · 414 trades